Envoy Medical, Inc.
Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 22 May 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 25 Nov 2025 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 28 Oct 2025 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Change of auditor (8-K Item 4.01)
The company reported a change of its independent auditor in a Form 8-K (Item 4.01) filed on 31 Mar 2026. Auditor changes are often routine (rotation, cost, mergers), but can follow disagreements over accounting.
More details →Envoy Medical, Inc. — Overview & Financial Snapshot
Envoy Medical, Inc. (NasdaqCM: COCH) is a Healthcare company, ranked #5,913 of 6,774 companies globally and #3,312 of 4,000 in United States on PositoAI, with a Positivity Score of 14,040. Its market capitalisation is ₹434.20 Cr ($46.00M), P/E ratio is -0.8 and P/B ratio is 12.45. It currently has 3 active red flags (PosiRed) and 1 yellow flag (PosiYellow, 2/10 points) on record.
For financial statements, ratio trends and score history, Go Deep →